ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Experience
Instructional Level [clear]
Presenter(s): Ruchi Kapila, MS, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Focusing on the perspectives of transgender and gender nonconforming (TGNC) individuals and communities, this session explores ways SLPs who currently--or aspire to--provide voice and communication services to TGNC individuals can better meet the holistic needs of this client population.
Credit(s): PDHs: 4.5, ASHA CEUs*: 0.45
Summary: Meta-therapy is an integral pillar of clinical practice; however, the lack of formal training in this area often makes the concept and application of meta-therapy elusive to clinicians. The goal of this SIG 3 activity is to disseminate how meta-therapy can be effectively utilized in the clinical domains of voice disorders, fluency, dysphagia, and cognitive communication and aphasia.
Presenter(s): Rene L Utianski, PhD, CCC-SLP, BC-ANCDS; Kristie A Spencer, PhD, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Motor speech disorders occur secondary to a wide variety of progressive neurological disorders. This course discusses strategies for the speaker, listener, and environment that clinicians can consider for managing progressive motor speech disorders. Presenters discuss management strategies in the context of concomitant decline of cognitive-linguistic and motoric function from neurodegenerative processes.
Presenter(s): Jennifer Gray, MS, CCC-SLP
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: Down syndrome is a genetic syndrome characterized by unique anatomical and physiological traits; medical complications affecting movement, respiration, feeding, and metabolism; intellectual disabilities; as well as dysarthria and other communication challenges. This on demand webinar shares evidence-based techniques that target motor speech, voice, fluency, and functional language to maximize intelligibility and comprehensibility of speech and language for individuals with Down syndrome.